BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 18043497)

  • 21. Proteomic expression profiling and identification of serum proteins using immobilized trypsin beads with MALDI-TOF/TOF.
    Karbassi ID; Nyalwidhe JO; Wilkins CE; Cazares LH; Lance RS; Semmes OJ; Drake RR
    J Proteome Res; 2009 Sep; 8(9):4182-92. PubMed ID: 19603828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
    Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
    Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of colorectal cancer.
    Liu C; Pan C; Shen J; Wang H; Yong L
    Int J Med Sci; 2011 Jan; 8(1):39-47. PubMed ID: 21234268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SELDI-TOF MS profiling of serum for detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis.
    Cheng L; Zhou L; Tao L; Zhang M; Cui J; Li Y
    J Cancer Res Clin Oncol; 2008 Jul; 134(7):769-76. PubMed ID: 18202856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of post-operative changes in serum protein expression profiles from colorectal cancer patients by MALDI-TOF mass spectrometry: a pilot methodological study.
    Liao CC; Mehta A; Ward NJ; Marsh S; Arulampalam T; Norton JD
    World J Surg Oncol; 2010 Apr; 8():33. PubMed ID: 20420661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral brush biopsy analysis by matrix assisted laser desorption/ionisation-time of flight mass spectrometry profiling--a pilot study.
    Remmerbach TW; Maurer K; Janke S; Schellenberger W; Eschrich K; Bertolini J; Hofmann H; Rupf S
    Oral Oncol; 2011 Apr; 47(4):278-81. PubMed ID: 21354855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients.
    Schaub NP; Jones KJ; Nyalwidhe JO; Cazares LH; Karbassi ID; Semmes OJ; Feliberti EC; Perry RR; Drake RR
    J Am Coll Surg; 2009 May; 208(5):970-8; discussion 978-80. PubMed ID: 19476873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum biomarker screening for the diagnosis of early gastric cancer using SELDI-TOF-MS.
    Li P; Zhang D; Guo C
    Mol Med Rep; 2012 Jun; 5(6):1531-5. PubMed ID: 22427025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mass spectrometry protein expression profiles in colorectal cancer tissue associated with clinico-pathological features of disease.
    Liao CC; Ward N; Marsh S; Arulampalam T; Norton JD
    BMC Cancer; 2010 Aug; 10():410. PubMed ID: 20691062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of novel serum biomarkers for gastric cancer by magnetic bead.
    Liu W; Gao X; Cai Q; Li J; Zhu Z; Li C; Yao X; Yang Q; Xiang M; Yan M; Zhu Z
    Front Biosci (Elite Ed); 2010 Jun; 2(3):961-71. PubMed ID: 20515767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis.
    Nanni P; Parisi D; Roda G; Casale M; Belluzzi A; Roda E; Mayer L; Roda A
    Rapid Commun Mass Spectrom; 2007; 21(24):4142-8. PubMed ID: 18022963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic potential of serum proteomic patterns in prostate cancer.
    BaƱez LL; Prasanna P; Sun L; Ali A; Zou Z; Adam BL; McLeod DG; Moul JW; Srivastava S
    J Urol; 2003 Aug; 170(2 Pt 1):442-6. PubMed ID: 12853795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SELDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of a boosting decision tree model for diagnosis of pancreatic cancer.
    Qian JY; Mou SH; Liu CB
    Asian Pac J Cancer Prev; 2012; 13(5):1911-5. PubMed ID: 22901146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is Lipidomic the Answer to the Search of a Biomarker for Organ Preservation Protocol in Head and Neck Squamous Cell Carcinoma?
    Laus AC; da Silva IDCG; Cordeiro FB; Lo Turco EG; de Souza Viana L; Carvalho AL
    Pathol Oncol Res; 2018 Oct; 24(4):931-935. PubMed ID: 29130149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MALDI/SELDI protein profiling of serum for the identification of cancer biomarkers.
    Cazares LH; Diaz JI; Drake RR; Semmes OJ
    Methods Mol Biol; 2008; 428():125-40. PubMed ID: 18287771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of matrix-assisted laser desorption/ionization-time of flight mass spectrometry proteomic profiling: identification of alpha 2-HS glycoprotein B-chain as a biomarker of diet.
    Mitchell BL; Yasui Y; Lampe JW; Gafken PR; Lampe PD
    Proteomics; 2005 May; 5(8):2238-46. PubMed ID: 15841498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
    O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
    Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of a multiple myeloma diagnostic model by magnetic bead-based MALDI-TOF mass spectrometry of serum and pattern recognition software.
    Wang QT; Li YZ; Liang YF; Hu CJ; Zhai YH; Zhao GF; Zhang J; Li N; Ni AP; Chen WM; Xu Y
    Anat Rec (Hoboken); 2009 Apr; 292(4):604-10. PubMed ID: 19301277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening and identification of potential biomarkers and establishment of the diagnostic serum proteomic model for the Traditional Chinese Medicine Syndromes of tuberculosis.
    Liu J; Li Y; Wei L; Yang X; Xie Z; Jiang T; Wang C; Zhang X; Xu D; Chen Z; Yang F; Li JC
    J Ethnopharmacol; 2014 Sep; 155(2):1322-31. PubMed ID: 25072359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.